Medtronic (Dublin) appears to be making good on its promise to invest in and acquire U.S. medical technology following its $42.9 billion purchase of Covidien. The company just acquired Medina Medical (Menlo Park, Calif.), a private firm it already had an ownership stake in, for $150 million plus milestone-based payments. Read More
